Loteprednol Etabonate Gel Shows Efficacy, Safety for Ocular Inflammation After Cataract Surgery
January 26th 2020Following cataract surgery, a submicron formulation of loteprednol etabonate (LE) gel, 0.38% administered three times daily (TID), is safe and effective for treating ocular inflammation with minimal risk of intraocular pressure (IOP) elevation, according to study findings.
Researchers Identify Biomarker for Spotted Fever Rickettsial
January 26th 2020Researchers recently discovered a sensitive and specific biomarker that may enable early diagnosis, treatment, and public awareness of spotted fever rickettsial infections, including Mediterranean spotted fever (MSF), according to a study published in the American Journal of Pathology.
Automated Tool Improves FEV1 Severity Detection in Patients With COPD, Study Shows
January 25th 2020Extracting lung function measurements from electronic health record (EHR) data through an automated tool, such as Microsoft SQL Server’s full-text search feature, may be efficient and improve the number of values available, leading to improved phenotyping of patients with COPD, according to study findings.
Nintedanib Exhibits Superior Cost-effectiveness to Pirfenidone for Treatment of IPF, Study Finds
January 25th 2020Researchers compared the cost-effectiveness of ninetedanib to pirfenidone for the treatment of idiopathic pulmonary fibrosis (IPF) and found nintedanib to be more cost-saving than pirfenidone, according to study findings.
Immune System Changes May Increase Efficacy of Treatment for Secondary Progressive MS
January 25th 2020Shifting towards an anti-inflammatory and suppressive homeostatic immune system may contribute to increased clinical efficacy of siponimod in patients with secondary progressive multiple sclerosis (SPMS), a recent study in JCI Insight reported.
Calcipotriene, Betamethasone Dipropionate Cream Meets Phase 3 Trial Endpoints
January 24th 2020A formulation of calcipotriene and betamethasone dipropionate cream met its primary endpoint for treating plaque psoriasis during its phase 3 trial in the European Union, according to an announcement from MC2 Therapeutics.
MTX Treatment May Increase Risk of Developing Late Left Ventricular Dysfunction in Patients with MS
January 20th 2020Patients with Multiple sclerosis (MS) treated with mitoxantrone (MTX)—an antracyclin drug used to treat chronic refractory MS—may be at an increased risk of developing early and late left ventricular (LV) dysfunction, suggesting the need for these patients to be periodically evaluated for complications, a recent study found.
Literature Review Suggests Genetic Skeletal Disorder Therapies Are Continuously Being Developed
January 20th 2020Despite challenges of rare disease drug development, genetic skeletal disorder (GSD) therapies continue to be developed through novel approaches such as drug repurposing and in-utero stem cell transplants, according to a recent review.
PBSC Mobilization Yields Sufficient CD34+ Cell Counts in Patients With MM and Lymphoma, Study Finds
January 19th 2020A study identifying the different factors influencing peripheral blood hematopoietic stem cell (PBSC) mobilization and collection in multiple myeloma (MM) and lymphoma cases determined that PBSC mobilization yielded sufficient CD34+ cell counts in both patients with MM and lymphoma, but the failure rates were high.
Study Indicates Link Between Severity of Diabetic Retinopathy, Subclinical CVD
January 19th 2020The presence and severity of diabetic retinopathy (DR) may be independently associated with subclinical cardiovascular disease (CVD) in patients with type 2 diabetes (T2D), suggesting the need for a rationalized screening for coronary artery disease in patients with T2D and DR.
Researchers Develop Trial Protocol on Ketogenic and Fasting Diets for Patients With MS
January 17th 2020For patients with multiple sclerosis, ketogenic diets and fasting diets may be potentially safe and inexpensive complementary treatment options. However, additional clinical studies and data are needed to prove this theory.
Steroids Ineffective in Treating One-Third of Acute GVHD Pediatric Patients, Study Finds
January 16th 2020A study investigating the clinical phenotype of acute graft-versus-host disease (GVHD) in children reveals that one-third of pediatric patients with the disease are not successfully treated with steroids as a primary GVHD therapy.
Researchers Conduct Review of Interleukin-17 Controversies Across Medical Fields
January 15th 2020Researchers outlined a comprehensive review of the common mechanisms through which interleukin-17 (IL-17) is considered a molecular target for developing novel biological therapies in several different fields of medicine, according to report findings.
Study Finds Cataract Surgery Simulator Training Decreased Operative Times for Resident Surgeons
January 13th 2020The operative times of third-year residents learning phacoemulsification may be significantly reduced by early and continuous implementation of mandatory virtual simulator surgical training before starting to perform intraocular surgery, according to a recent study.
Study Links Short Sleep Duration to Male Sex, Old Age, and High Coffee Intake
January 5th 2020The researchers reported that aging brings degeneration of the circadian pacemaker, a progressive decline in melatonin output and decrease in rhythm amplitude which contributes to increasing sleep fragmentation and waking up earlier in the morning.
Narcolepsy Management Must Be Tailored for Each Patient, Report Suggests
December 18th 2019Narcolepsy management should be a combination of behavioral and pharmacologic strategies that are tailored to the patient with consideration of the impact of symptoms and how they may evolve, according to a recent review aiming to improve narcolepsy diagnosis and management.